azacitidine has been researched along with Chylopericardium in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjos, R; Fogaça da Mata, M; Gonçalves, JP; Madeira, M; Rato, J; Teixeira, A; Vieira Martins, M | 1 |
| Aggarwal, P; Chu, B; Venkatakrishnan, A | 1 |
| Goo, K; Roswarski, J; Uy, R | 1 |
| Fernández-Sojo, J; Oliveras Vilà, T; Ribera, JM; Vives, S | 1 |
| Laufer, CB; Roberts, O | 1 |
5 other study(ies) available for azacitidine and Chylopericardium
| Article | Year |
|---|---|
Azacitidine-induced massive pericardial effusion in a child with myelodysplastic syndrome.
Topics: Adult; Azacitidine; Cardiac Tamponade; Child; Humans; Male; Myelodysplastic Syndromes; Pericardial Effusion; Pericardiocentesis | 2022 |
Safety Signal between Azacitidine and Pericarditis.
Topics: Azacitidine; Cardiac Tamponade; Humans; Pericardial Effusion; Pericarditis; Pericarditis, Constrictive | 2023 |
Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Humans; Male; Myelodysplastic Syndromes; Pericardial Effusion; Pleural Effusion | 2019 |
[Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome].
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Azacitidine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Hepatomegaly; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Serositis | 2014 |
Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine.
Topics: Aged; Azacitidine; Female; Fever; Humans; Hypotension; Leukemia, Myeloid, Acute; Pericardial Effusion; Syndrome | 2015 |